Physician
Mchugh, Paul
Mchugh, Paul was paid $189K by Medicaid between Jan 2018 and Dec 2018, across 27 billing codes. Its largest line is 95004, Percutaneous tests with allergenic extracts, immediate type reaction — 56% of everything it billed.
33Billing provider infoMCHUGH, PAUL
LAS VEGAS, NV 89102
LAS VEGAS, NV 89102
33aNPI1558327692assigned 04/26/2006
33bProvider typeFamily Medicine Physician
28Total paid$189K
24GClaims2,393
24DCodes billed27
24AFirst – last monthJan 2018 – Dec 2018
Compared with peers
Next to other Family Medicine Physician providers in Nevada
Rank by total paid#72 of 388
Median peer was paid$27K
This provider vs. median7.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,393 | $189K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 56% | 259 | 248 | $107K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 786 | 699 | $52K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 7.1% | 337 | 319 | $13K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.8% | 68 | 63 | $5K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 15 | 14 | $1K |
| 94060 | <1% | 27 | 26 | $1K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 23 | 21 | $1K |
| 94729 | <1% | 27 | 26 | $1K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 18 | 18 | $1K |
| 94727 | <1% | 27 | 26 | $937.94 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 57 | 53 | $761.68 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 20 | 20 | $706.06 |
15 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 65 | $684.62 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 37 | $536.63 |
| 92561 | <1% | 13 | $438.62 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 148 | $437.82 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $288.86 |
| 99188 | <1% | 15 | $184.50 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 164 | $118.46 |
| 94200 | <1% | 27 | $110.05 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 37 | $65.35 |
| 85018 | <1% | 37 | $64.26 | |
| 81000 | <1% | 32 | $48.58 | |
| 94760 | <1% | 38 | $42.75 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 38 | $9.64 |
| 99000 | 0% | 50 | $0.00 | |
| 99173 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.